Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
BENZYDAMINE HYDROCHLORIDE
PCO Manufacturing
0.15 %w/v
Oromucosal Spray
2011-05-20
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Difflam Spray, 0.15% w/v, Oromucosal Spray 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each puff (175 microlitres) contains 262.5 micrograms of benzydamine hydrochloride (0.15% w/v). Excipient(s) : includes methyl parahydroxybenzoate (E218) and ethanol For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Oromucosal spray _Product imported from the UK_ Difflam spray is a metered dose spray containing a clear, colourless oromucosal spray solution 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS As an adjunct in the symptomatic relief of painful inflammatory conditions of the throat and mouth. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION FOR OROMUCOSAL ADMINISTRATION. ADULTS AND ELDERLY: 4 to 8 puffs, 1½-3 hourly. CHILDREN (6-12): 4 puffs, 1½-3 hourly. CHILDREN UNDER 6: One puff to be administered per 4 kg body weight, up to a maximum of 4 puffs, 1½-3 hourly. Because of the small amount of drug applied, elderly patients can receive the same dose as adults. The spray should be directed onto the affected area. Uninterrupted treatment should not exceed seven days, except under medical supervision. 4.3 CONTRAINDICATIONS Use in patient with a known hypersensitivity (eg bronchospasm, rhinitis, urticaria) to this product. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Avoid contact with the eyes. If the condition is aggravated or not improved use should cease. Contains methyl parahydroxybenzoate (E218). May cause allergic reactions (possibly delayed). This medicinal product contains small amounts of ethanol (alcohol) less than 100mg per dose. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 25/05/2011_ _CRN 2067086_ _page numbe Read the complete document